Research map: Severe invasive pneumococcal disease beyond current vaccination recommendations: implications for higher-valency vaccines

Back to the article

Papers in this map

  1. Serotype distribution of Streptococcus pneumoniae causing invasive disease in children in the post-PCV era: A systematic review and meta-analysis · Evelyn Balsells · 2017 · 406 citations · Cited by this paper
  2. Risk factors for multidrug resistance and mortality in healthcare-associated neonatal gram-negative bloodstream infections · 2026 · Related
  3. Which individuals are at increased risk of pneumococcal disease and why? Impact of COPD, asthma, smoking, diabetes, and/or chronic heart disease on community-acquired pneumonia and invasive pneumococcal disease: Table 1 · Antoní Torres · 2015 · 345 citations · Cited by this paper
  4. Clinical predictors, microbiological profile, and outcomes of bacteremia in patients with cellulitis: a 6-year retrospective cohort study · 2026 · Related
  5. The Influence of Chronic Illnesses on the Incidence of Invasive Pneumococcal Disease in Adults · Moe H. Kyaw · 2005 · 334 citations · Cited by this paper
  6. How long should we keep clinical isolates involved in bone and joint infections in microbiology laboratories? · 2026 · Related
  7. Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Invasive Pneumococcal Disease and Risk of Pneumococcal Coinfection With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Prospective National Cohort Study, England · Zahin Amin‐Chowdhury · 2020 · 174 citations · Cited by this paper
  8. Molecular epidemiology and pharmacokinetic–pharmacodynamic analysis of Neisseria gonorrhoeae strains in Northern Spain · 2026 · Related
  9. Divergent serotype replacement trends and increasing diversity in pneumococcal disease in high income settings reduce the benefit of expanding vaccine valency · Alessandra Løchen · 2020 · 168 citations · Cited by this paper
  10. A review of bloodstream infections−pathogens, pathogenesis, diagnostic strategies, treatment methods−challenges and future aspects · 2026 · Related
  11. Expanded Recommendations for Use of Pneumococcal Conjugate Vaccines Among Adults Aged ≥50 Years: Recommendations of the Advisory Committee on Immunization Practices — United States, 2024 · Miwako Kobayashi · 2025 · 141 citations · Cited by this paper
  12. Independent risk factors for refractory mycoplasma pneumoniae pneumonia in children: a multivariate analysis · 2026 · Related
  13. Unusual manifestations of invasive pneumococcal infection · Stephanie N. Taylor · 1999 · 130 citations · Cited by this paper
  14. Lytic activity of F8-like phage φSPM-1 against One Health lineages of carbapenem-resistant Pseudomonas aeruginosa · 2026 · Related
  15. Use of 21-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Recommendations of the Advisory Committee on Immunization Practices — United States, 2024 · Miwako Kobayashi · 2024 · 126 citations · Cited by this paper
  16. DTT-based biofilm and conventional intraoperative cultures for the detection of prosthetic joint infections: a comparative study · 2026 · Related
  17. Reemergence of Invasive Pneumococcal Disease in Germany During the Spring and Summer of 2021 · Stephanie Perniciaro · 2022 · 95 citations · Cited by this paper
  18. Nocardia antimicrobial susceptibility testing by microdilution: evaluation of ready-to-use plate including tedizolid and meropenem · 2026 · Related
  19. Serotype distribution of remaining invasive pneumococcal disease after extensive use of ten-valent and 13-valent pneumococcal conjugate vaccines (the PSERENADE project): a global surveillance analysis · Maria Garcia Quesada · 2024 · 89 citations · Cited by this paper
  20. Recombination and diversifying selection drive the adaptive evolution of tet(X)-Positive Escherichia coli · 2026 · Related
  21. Prognostic factors for mortality in invasive pneumococcal disease in adult: a system review and meta-analysis · Hao Chen · 2021 · 78 citations · Cited by this paper
  22. Effects of Immunocompromise and Comorbidities on Pneumococcal Serotypes Causing Invasive Respiratory Infection in Adults: Implications for Vaccine Strategies · Manel Luján · 2013 · 50 citations · Cited by this paper
  23. Pneumococcal and influenza vaccination coverage among at-risk adults: A 5-year French national observational study · Benjamin Wyplosz · 2022 · 46 citations · Cited by this paper
  24. Future immunisation strategies to prevent Streptococcus pneumoniae infections in children and adults · Bernice Ramos · 2025 · 31 citations · Cited by this paper
  25. Host–pathogen interactions and prognosis of critically ill immunocompetent patients with pneumococcal pneumonia: the nationwide prospective observational STREPTOGENE study · Jean‐Pierre Bédos · 2018 · 25 citations · Cited by this paper
  26. Global distribution and characteristics of pneumococcal serotypes in adults · Haruka Maeda · 2025 · 22 citations · Cited by this paper
  27. The Impact of Pneumococcal Conjugate Vaccine (PCV) Coverage Heterogeneities on the Changing Epidemiology of Invasive Pneumococcal Disease in Switzerland, 2005–2019 · Oluwaseun Rume-Abiola Oyewole · 2021 · 20 citations · Cited by this paper
  28. Severe community-acquired Streptococcus pneumoniae bacterial meningitis: clinical and prognostic picture from the intensive care unit · María Martín Cerezuela · 2023 · 20 citations · Cited by this paper
  29. Chronic Disease and Immunosuppression Increase the Risk for Nonvaccine Serotype Pneumococcal Disease: A Nationwide Population-based Study · Pontus Nauclér · 2021 · 18 citations · Cited by this paper
  30. The rise of serotype 8 is associated with lineages and mutations in the capsular operon with different potential to produce invasive pneumococcal disease · Covadonga Pérez-García · 2025 · 17 citations · Cited by this paper
  31. Pneumococcal vaccine uptake among high-risk adults and children in Italy: results from the OBVIOUS project survey · Zeno Di Valerio · 2024 · 16 citations · Cited by this paper
  32. Effectiveness of 13-valent pneumococcal conjugate vaccine against vaccine-type invasive pneumococcal disease in older adults · Amber Hsiao · 2024 · 13 citations · Cited by this paper
  33. Pneumococcal bacteraemia in adults over a 10‐year period (2011–2020): a clinical and serotype analysis · Clinton Colaco · 2023 · 6 citations · Cited by this paper
  34. Comorbidities and their impact on in-hospital mortality in hospitalized adult patients with bacterial community-acquired pneumonia: a cohort study · Ting Yuan David Cheng · 2025 · 6 citations · Cited by this paper
  35. Vaccination Outcomes and Recommendations Among Older Adults in a Gastroenterology and Hepatology Practice · Megan K. Lutz · 2025 · 3 citations · Cited by this paper
  36. Pneumococcal vaccination offer and schedules in adults in EU countries: An update · Manuela Chiavarini · 2025 · 3 citations · Cited by this paper

Source: OpenAlex (CC0)